CollPlant Biotechnologies (CLGN) Selling, General & Administrative (2017 - 2026)
CollPlant Biotechnologies (CLGN) Selling, General & Administrative (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - | -10.08 Mn |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | 2.17 Mn |
| 4 | BeOne Medicines | 472.40 Bn | 467.61 Bn | 1.35 Bn | 555.10 Mn |
| 5 | Vertex Pharmaceuticals | 122.23 Bn | 114.98 Bn | 2.59 Bn | 493.70 Mn |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.29 Bn | 3.31 Bn | 647.70 Mn |
| 7 | Belite Bio | 62.46 Bn | 62.46 Bn | - | 17.02 Mn |
| 8 | Argenx Se | 55.94 Bn | 50.76 Bn | 1.41 Bn | 1.13 Bn |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn | 322.55 Mn |
| 10 | CollPlant Biotechnologies | 4.28 Mn | 4.28 Mn | -243,000.00 | 1.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 30, 2026 | 1.19 Mn |
| Dec 31, 2025 | 1.04 Mn |
| Sep 30, 2025 | 1.23 Mn |
| Jun 30, 2025 | 1.16 Mn |
| Mar 30, 2025 | 1.41 Mn |
| Dec 31, 2024 | 1.32 Mn |
| Sep 30, 2024 | 1.41 Mn |
| Jun 30, 2024 | 1.42 Mn |
| Mar 31, 2024 | 1.48 Mn |
| Dec 31, 2023 | 1.48 Mn |
| Sep 30, 2023 | 1.67 Mn |
| Jun 30, 2023 | 1.32 Mn |
| Mar 31, 2023 | 1.53 Mn |
| Dec 31, 2022 | 2.04 Mn |
| Sep 30, 2022 | 1.54 Mn |
| Jun 30, 2022 | 1.61 Mn |
| Mar 31, 2022 | 1.56 Mn |
| Dec 31, 2021 | 1.38 Mn |
| Sep 30, 2021 | 1.18 Mn |
| Jun 30, 2021 | 1.42 Mn |